1.Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand.
Srivicha KRUDSOOD ; Noppadon TANGPUKDEE ; Sant MUANGNOICHAROEN ; Vipa THANACHARTWET ; Nutthanej LUPLERTLOP ; Siripan SRIVILAIRIT ; Polrat WILAIRATANA ; Shigeyuki KANO ; Pascal RINGWALD ; Sornchai LOOAREESUWAN
The Korean Journal of Parasitology 2007;45(2):111-114
Chloroquine remains the drug of choice for the treatment of vivax malaria in Thailand. Mixed infections of falciparum and vivax malaria are also common in South-East Asia. Laboratory confirmation of malaria species is not generally available. This study aimed to find alternative regimens for treating both malaria species by using falciparum antimalarial drugs. From June 2004 to May 2005, 98 patients with Plasmodium vivax were randomly treated with either artemether-lumefantrine (n = 47) or chloroquine (n = 51). Both treatments were followed by 15 mg of primaquine over 14 days. Adverse events and clinical and parasitological outcomes were recorded and revealed similar in both groups. The cure rate was 97.4% for the artemether-lumefantrine treated group and 100% for the chloroquine treated group. We concluded that the combination of artemether-lumefantrine and primaquine was well tolerated, as effective as chloroquine and primaquine, and can be an alternative regimen for treatment of vivax malaria especially in the event that a mixed infection of falciparum and vivax malaria could not be ruled out.
Adolescent
;
Aged
;
Animals
;
Antimalarials/adverse effects/*therapeutic use
;
Artemisinins/adverse effects/*therapeutic use
;
Chloroquine/adverse effects/*therapeutic use
;
Drug Therapy, Combination
;
Ethanolamines/adverse effects/*therapeutic use
;
Female
;
Fluorenes/adverse effects/*therapeutic use
;
Humans
;
Malaria, Vivax/*drug therapy
;
Male
;
Middle Aged
;
Parasitemia
;
Plasmodium vivax/drug effects
;
Primaquine/therapeutic use
;
Thailand
;
Treatment Outcome
2.An Imported Case of Severe Falciparum Malaria with Prolonged Hemolytic Anemia Clinically Mimicking a Coinfection with Babesiosis.
Young Ju NA ; Jong Yil CHAI ; Bong Kwang JUNG ; Hyun Jung LEE ; Ji Young SONG ; Ji Hye JE ; Ji Hye SEO ; Sung Hun PARK ; Ji Seon CHOI ; Min Ja KIM
The Korean Journal of Parasitology 2014;52(6):667-672
While imported falciparum malaria has been increasingly reported in recent years in Korea, clinicians have difficulties in making a clinical diagnosis as well as in having accessibility to effective anti-malarial agents. Here we describe an unusual case of imported falciparum malaria with severe hemolytic anemia lasting over 2 weeks, clinically mimicking a coinfection with babesiosis. A 48-year old Korean man was diagnosed with severe falciparum malaria in France after traveling to the Republic of Benin, West Africa. He received a 1-day course of intravenous artesunate and a 7-day course of Malarone (atovaquone/proguanil) with supportive hemodialysis. Coming back to Korea 5 days after discharge, he was readmitted due to recurrent fever, and further treated with Malarone for 3 days. Both the peripheral blood smears and PCR test were positive for Plasmodium falciparum. However, he had prolonged severe hemolytic anemia (Hb 5.6 g/dl). Therefore, 10 days after the hospitalization, Babesia was considered to be potentially coinfected. A 7-day course of Malarone and azithromycin was empirically started. He became afebrile within 3 days of this babesiosis treatment, and hemolytic anemia profiles began to improve at the completion of the treatment. He has remained stable since his discharge. Unexpectedly, the PCR assays failed to detect DNA of Babesia spp. from blood. In addition, during the retrospective review of the case, the artesunate-induced delayed hemolytic anemia was considered as an alternative cause of the unexplained hemolytic anemia.
Anemia, Hemolytic/chemically induced/*etiology/*pathology
;
Anti-Bacterial Agents/therapeutic use
;
Antimalarials/therapeutic use
;
Artemisinins/adverse effects/therapeutic use
;
Atovaquone/therapeutic use
;
Azithromycin/therapeutic use
;
Babesiosis/complications/*diagnosis/drug therapy/*pathology
;
Benin
;
Blood/parasitology
;
Coinfection/diagnosis/pathology
;
Drug Combinations
;
France
;
Humans
;
Korea
;
Malaria, Falciparum/complications/*diagnosis/drug therapy/*pathology
;
Male
;
Middle Aged
;
Plasmodium falciparum/*isolation & purification
;
Proguanil/therapeutic use
;
Travel
;
Treatment Outcome